D-0387-2021 Class III Terminated
FDA drug recall D-0387-2021 was initiated by Nomax Inc on Apr 13, 2021 and is designated Class III. Reason for recall: Subpotent Drug The recall status is terminated (terminated Sep 28, 2023). Affected quantity: 78 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- May 26, 2021
- Initiation Date
- Apr 13, 2021
- Termination Date
- Sep 28, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 78 cartons
Product description
Dry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodium), 100 Sterile Strips (50 Pouches of 2 Strips Each), Manufactured by: Nomax, Inc, St. Louis, MO 63123, NDC: 51801-008-15
Reason for recall
Subpotent Drug
Distribution pattern
Nationwide USA
Code information
LOT 13336 EXP 07/23
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0387-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026